FDA Adverse Event Malfunction Summary report: N

APEX MONORAIL

MDR report key: 1191924 · Received October 1, 2008

Report

Report Number
2134265-2008-02843
Event Type
Malfunction
Date Received
October 1, 2008
Date of Event
September 5, 2008
Report Date
September 5, 2008
Manufacturer
BOSTON SCIENTIFIC
Product Code
LOX
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A PERCUTANEOUS CORONARY INTERVENTION PROCEDURE A SHAFT BREAK OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY CALCIFIED AND NON TORTUOUS BIFURCATION OF THE LEFT ANTERIOR DESCENDING ARTERY (LAD) AND FIRST DIAGONAL. THE LESION WAS PREDILATED WITH A 2.5X12MM NON BSC DEVICE AND AFTER STENTING OF THE BIFURCATION THE PHYSICIAN DECIDED TO PERFORM A FINAL KISSING BALLOON TECHNIQUE. A 2.5X12MM NON BSC DEVICE WAS INTRODUCED INTO THE LESION AND THEN A 2.5X12MM APEX MONORAIL DEVICE IN A 6F GUIDE NON BSC GUIDE CATHETER WAS INTRODUCED. HOWEVER, WHILE INTRODUCING THE APEX DEVICE, THE SHAFT OF THE DEVICE BROKE. THE APEX BALLOON WAS NOT USED AND WAS EASILY WITHDRAWN BECAUSE IT WAS IN THE BEGINNING OF THE GUIDE CATHETER. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE WITH NO PT COMPLICATIONS REPORTED. THE PT'S CURRENT CONDITION IS LISTED AS "STABLE". THIS PRODUCT IS ONLY OUS APPROVED BUT IS SIMILAR TO A MARKETED US DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 APEX MONORAIL NA LOX BOSTON SCIENTIFIC 2.5X12MM 11572712

Patients

Seq Age Sex Outcome Treatment
1 76 YR